Delivery Order SPE2DB24D2018-SPE2DB25FWWG9
- Not listed
- The Defense Logistics Agency awarded a Delivery Order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor and critical vendor for federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,771.04 for 30 tablets of Orgovyx 120 mg on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is funded through the Medical Supply Chain, a defense-oriented federal agency supporting military and veteran healthcare systems. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, a pharmaceutical product delivered to the company's facility in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively on September 10, 2025, with completion anticipated by October 1, 2025. This delivery order represents a child contract under AmerisourceBergen Drug Corp's...
- This delivery order, awarded on July 30, 2025, to AmerisourceBergen Drug Corp supplies 30 tablets of Orgovyx 120 mg under a firm fixed price contract valued at $2,771.04. The award is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 20, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is funded through the Defense agency's Medical Supply Chain and represents a child contract under a...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with an ultimate completion date of August 25, 2025. This non-set-aside contract was competitively awarded on August 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $1,385.52 on August 27, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). The contract, which is not set-aside and carries an ultimate completion date of September 18, 2025, is funded through the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense. This delivery order represents a single-line pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, a pharmaceutical product used in hormone therapy. This competitively awarded, firm fixed-price contract was issued on September 8, 2025, with an ultimate completion date of September 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $8,313.12 for 30 tablets of Orgovyx 120 mg on September 12, 2025, with an ultimate completion date of October 3, 2025. This non-competitive award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The delivery order will be...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWG9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,771.04 by the Defense Logistics Agency for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract representing a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company holds a significant prime IDC valued at $999,999,999.00 running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Defense Logistics Agency Medical Supply Chain regularly issues delivery orders against AmerisourceBergen's prime contract vehicle to fulfill pharmaceutical needs across federal medical procurement, including support to the Defense Health Agency and U.S. Coast Guard. Orgovyx is a prescription medication used in hormone therapy, reflecting the company's demonstrated capability to supply specialized pharmaceutical products across multiple therapeutic domains. The contract's delivery order structure and firm fixed pricing are consistent with AmerisourceBergen's established federal contract portfolio, which demonstrates the company's versatility in fulfilling federal medical supply requirements ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/18/25 |